تصفح COVID-19 Research حسب الموضوع "MERS"
السجلات المعروضة 1 -- 4 من 4
-
Development of remdesivir repositioning as a nucleotide analog against COVID-19 RNA dependent RNA polymerase
( Taylor and Francis Ltd. , 2020 , Article)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative representative of a severe respiratory illness resulted in widespread human infections and deaths in nearly all of the countries since late 2019. ... -
Individual and network characteristic associated with hospital-acquired Middle East Respiratory Syndrome coronavirus
( Elsevier Ltd , 2019 , Article)Background: During outbreaks of infectious diseases, transmission of the pathogen can form networks of infected individuals connected either directly or indirectly. Methods: Network centrality metrics were used to characterize ... -
Neutralization of MERS coronavirus through a scalable nanoparticle vaccine
( Springer Nature , 2021 , Article)MERS-CoV continues to cause human outbreaks, so far in 27 countries worldwide following the first registered epidemic in Saudi Arabia in 2012. In this study, we produced a nanovaccine based on virus-like particles (VLPs). ... -
The expression level of angiotensin-converting enzyme 2 determines the severity of COVID-19: lung and heart tissue as targets
( Taylor and Francis Ltd. , 2020 , Article)Researchers have reported some useful information about the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leading to CoV disease 2019 (COVID-19). Several studies have been performed in order to develop ...